MedTrace Logo

A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants

NCT05395104 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2023-12-14

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the effect of repeated doses of cefiderocol on the PK of midazolam.

Conditions

  • Healthy Volunteers

Interventions

DRUG

Midazolam

Syrup for oral administration

DRUG

Cefiderocol

Liquid for intravenous infusion

Sponsors & Collaborators

  • Shionogi

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-24
Primary Completion
2022-07-13
Completion
2022-07-13
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05395104 on ClinicalTrials.gov